{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T17:10:22Z","timestamp":1784567422260,"version":"3.55.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T00:00:00Z","timestamp":1536537600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1038\/s41433-018-0203-3","type":"journal-article","created":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T09:56:19Z","timestamp":1536573379000},"page":"349-352","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Long-term outcome of flexible onabotulinum toxin A treatment in facial dystonia"],"prefix":"10.1038","volume":"33","author":[{"given":"John C","family":"Bladen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilan","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maribel","family":"Favor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marizol","family":"Dizon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Litwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raman","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,10]]},"reference":[{"key":"203_CR1","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1212\/WNL.37.4.616","volume":"37","author":"J Jankovic","year":"1987","unstructured":"Jankovic J, Orman J. Botulinum A toxin for cranial-cervical dystonia: a double-blind, placebo-controlled study. Neurology. 1987;37:616\u201323.","journal-title":"Neurology"},{"key":"203_CR2","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/00006534-198908000-00027","volume":"84","author":"RP Clark","year":"1989","unstructured":"Clark RP, Berris CE. Botulinum toxin: a treatment for facial asymmetry caused by facial nerve paralysis. Plast Reconstr Surg. 1989;84:353\u20135.","journal-title":"Plast Reconstr Surg"},{"key":"203_CR3","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1002\/mus.880180708","volume":"18","author":"P Bergh Van den","year":"1995","unstructured":"Van den Bergh P, Francart J, Mourin S, Kollmann P, Laterre EC. Five-year experience in the treatment of focal movement disorders with low-dose Dysport botulinum toxin. Muscle Nerve. 1995;18:720\u20139.","journal-title":"Muscle Nerve"},{"key":"203_CR4","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/mds.870090216","volume":"9","author":"P Greene","year":"1994","unstructured":"Greene P, Fahn S, Diamond B. Development of resistance to botulinum toxin type A in patients with torticollis. Mov Disord. 1994;9:213\u20137.","journal-title":"Mov Disord"},{"key":"203_CR5","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3111\/13696998.2011.653726","volume":"15","author":"KD Sethi","year":"2012","unstructured":"Sethi KD, Rodriguez R, Olayinka B. Satisfaction with botulinum toxin treatment: a cross-sectional survey of patients with cervical dystonia. J Med Econ. 2012;15:419\u201323.","journal-title":"J Med Econ"},{"key":"203_CR6","first-page":"311","volume":"43","author":"ZM Hawamdeh","year":"2007","unstructured":"Hawamdeh ZM, Ibrahim AI, Al-Qudah AA. Long-term effect of botulinum toxin (A) in the management of calf spasticity in children with diplegic cerebral palsy. Eura Med. 2007;43:311\u20138.","journal-title":"Eura Med"},{"key":"203_CR7","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/j.1469-8749.2008.03264.x","volume":"51","author":"P Kanovsky","year":"2009","unstructured":"Kanovsky P, Bares M, Severa S, Richardson A. Long-term efficacy and tolerability of 4-monthly versus yearly botulinum toxin type A treatment for lower-limb spasticity in children with cerebral palsy. Dev Med Child Neurol. 2009;51:436\u201345.","journal-title":"Dev Med Child Neurol"},{"key":"203_CR8","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1590\/S0004-27492006000400013","volume":"69","author":"MF Cronemberger","year":"2006","unstructured":"Cronemberger MF, Mendonca TS, Bicas HE. [Botulinum toxin treatment for horizontal strabismus in children with cerebral palsy]. Arq Bras Oftalmol. 2006;69:523\u20139.","journal-title":"Arq Bras Oftalmol"},{"key":"203_CR9","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00702-005-0323-3","volume":"113","author":"P Roggenkamper","year":"2006","unstructured":"Roggenkamper P, Jost WH, Bihari K, Comes G, Grafe S. Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm. J Neural Transm (Vienna). 2006;113:303\u201312.","journal-title":"J Neural Transm (Vienna)"},{"key":"203_CR10","first-page":"1181","volume":"24","author":"CL Hankins","year":"1998","unstructured":"Hankins CL, Strimling R, Rogers GS. Botulinum A toxin for glabellar wrinkles. Dose and response. Dermatol Surg. 1998;24:1181\u20133.","journal-title":"Dermatol Surg"},{"key":"203_CR11","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1097\/DSS.0000000000000357","volume":"41","author":"J Carruthers","year":"2015","unstructured":"Carruthers J, Rivkin A, Donofrio L, Bertucci V, Somogyi C, Lei X, et al. A multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of repeated onabotulinumtoxinA treatments in subjects with Crow\u2019s feet lines and glabellar lines. Dermatol Surg. 2015;41:702\u201311.","journal-title":"Dermatol Surg"},{"key":"203_CR12","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1097\/01.prs.0000279377.86280.8d","volume":"120","author":"MA Stotland","year":"2007","unstructured":"Stotland MA, Kowalski JW, Ray BB. Patient-reported benefit and satisfaction with botulinum toxin type A treatment of moderate to severe glabellar rhytides: results from a prospective open-label study. Plast Reconstr Surg. 2007;120:1386\u201393. discussion 1394","journal-title":"Plast Reconstr Surg"},{"key":"203_CR13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1524-4725.1992.tb03295.x","volume":"18","author":"JD Carruthers","year":"1992","unstructured":"Carruthers JD, Carruthers JA. Treatment of glabellar frown lines with C. botulinum-A exotoxin. J Dermatol Surg Oncol. 1992;18:17\u201321.","journal-title":"J Dermatol Surg Oncol"},{"key":"203_CR14","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/BF00941758","volume":"235","author":"Z Nussgens","year":"1997","unstructured":"Nussgens Z, Roggenkamper P. Comparison of two botulinum-toxin preparations in the treatment of essential blepharospasm. Graefes Arch Clin Exp Ophthalmol. 1997;235:197\u20139.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"203_CR15","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1185\/030079905X36396","volume":"21","author":"K Bihari","year":"2005","unstructured":"Bihari K. Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia, and hemifacial spasm. Curr Med Res Opin. 2005;21:433\u20138.","journal-title":"Curr Med Res Opin"},{"key":"203_CR16","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/ceo.12165","volume":"42","author":"OH Ababneh","year":"2014","unstructured":"Ababneh OH, Cetinkaya A, Kulwin DR. Long-term efficacy and safety of botulinum toxin A injections to treat blepharospasm and hemifacial spasm. Clin Exp Ophthalmol. 2014;42:254\u201361.","journal-title":"Clin Exp Ophthalmol"},{"key":"203_CR17","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.3109\/09638280903514697","volume":"32","author":"ED Toffola","year":"2010","unstructured":"Toffola ED, Furini F, Redaelli C, Prestifilippo E, Bejor M. Evaluation and treatment of synkinesis with botulinum toxin following facial nerve palsy. Disabil Rehabil. 2010;32:1414\u20138.","journal-title":"Disabil Rehabil"},{"key":"203_CR18","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00702-014-1278-z","volume":"122","author":"K Kollewe","year":"2015","unstructured":"Kollewe K, Mohammadi B, Kohler S, Pickenbrock H, Dengler R, Dressler D. Blepharospasm: long-term treatment with either Botox(R), Xeomin(R) or Dysport(R). J Neural Transm (Vienna). 2015;122:427\u201331.","journal-title":"J Neural Transm (Vienna)"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41433-018-0203-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41433-018-0203-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41433-018-0203-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:05:13Z","timestamp":1684616713000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-018-0203-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,10]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["203"],"URL":"https:\/\/doi.org\/10.1038\/s41433-018-0203-3","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,10]]},"assertion":[{"value":"18 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}